SCLX CIK: 1820190

Scilex Holding Co

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
27.7
FY22:
27.2
FY23:
31.1
FY24:
167
FY25:
126
(positive)
Change from FY21 to FY25
millions USD
FY21:
−35.8
FY22:
−50.6
FY23:
−105
FY24:
−83.4
FY25:
−346
(positive)
Change from FY21 to FY23
millions USD
FY21:
−32.1
FY22:
−46.7
FY23:
−108
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−88.4
FY22:
−23.4
FY23:
−114
FY24:
−72.8
FY25:
−374
(positive)
Change from FY21 to FY25
millions USD
FY21:
−88.4
FY22:
−23.4
FY23:
−114
FY24:
−72.8
FY25:
−374

All amounts in millions USD Data sources:SEC EDGARTwelve Data